Radiotherapy for mesothelioma

Craig W. Stevens, Kenneth M. Forster, W. Roy Smythe, David Rice

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

Three to four thousand cases of malignant pleural mesothelioma will occur in the United States this year. Single-modality therapy with radiation plays a role for palliation. Radiation can prevent tumor recurrence at drain/instrumentation sites and provide symptomatic relief of pain and other complaints. Combinations of surgery and radiation also have been attempted with curative intent. The best local control has been found - EPP followed by radiotherapy. Locoregional tumor recurrence can be dramatically reduced with combinations of extrapleural pneumonectomy and radiation therapy. Survival in aggressively treated early-stage patients is excellent. However, the preponderance of death from distant metastases makes the development of better systemic therapy essential. Better therapy also must be developed for patients who are not candidates for extrapleural pneumonectomy.

Original languageEnglish (US)
Pages (from-to)1099-1115
Number of pages17
JournalHematology/Oncology Clinics of North America
Volume19
Issue number6
DOIs
StatePublished - Dec 2005

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Radiotherapy for mesothelioma'. Together they form a unique fingerprint.

Cite this